These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 22194489)

  • 41. Diagnostic Performance of Split-Bolus Portal Venous Phase Dual-Energy CT Urography in Patients With Hematuria.
    Chen CY; Tsai TH; Jaw TS; Lai ML; Chao MF; Liu GC; Hsu JS
    AJR Am J Roentgenol; 2016 May; 206(5):1013-22. PubMed ID: 26934212
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dual-Source Dual-Energy CT in Submandibular Sialolithiasis: Reliability and Radiation Burden.
    Pulickal GG; Singh D; Lohan R; Chawla A
    AJR Am J Roentgenol; 2019 Dec; 213(6):1291-1296. PubMed ID: 31573848
    [No Abstract]   [Full Text] [Related]  

  • 43. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values.
    Korobkin M; Brodeur FJ; Yutzy GG; Francis IR; Quint LE; Dunnick NR; Kazerooni EA
    AJR Am J Roentgenol; 1996 Mar; 166(3):531-6. PubMed ID: 8623622
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients.
    Boland GW; Blake MA; Holalkere NS; Hahn PF
    AJR Am J Roentgenol; 2009 Apr; 192(4):956-62. PubMed ID: 19304700
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of Small Incidental Indeterminate Hypoattenuating Hepatic Lesions: Added Value of Single-Phase Contrast-Enhanced Dual-Energy CT Material Attenuation Analysis.
    Patel BN; Rosenberg M; Vernuccio F; Ramirez-Giraldo JC; Nelson R; Farjat A; Marin D
    AJR Am J Roentgenol; 2018 Sep; 211(3):571-579. PubMed ID: 30040464
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Variability of CT Attenuation Measurements in Virtual Unenhanced Images Generated Using Multimaterial Decomposition from Fast Kilovoltage-switching Dual-energy CT.
    Kaza RK; Raff EA; Davenport MS; Khalatbari S
    Acad Radiol; 2017 Mar; 24(3):365-372. PubMed ID: 27769822
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of true unenhanced and virtual unenhanced (VUE) attenuation values in abdominopelvic single-source rapid kilovoltage-switching spectral CT.
    Borhani AA; Kulzer M; Iranpour N; Ghodadra A; Sparrow M; Furlan A; Tublin ME
    Abdom Radiol (NY); 2017 Mar; 42(3):710-717. PubMed ID: 27864600
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Attenuation and Degree of Enhancement With Conventional 120-kVp Polychromatic CT and 70-keV Monochromatic Rapid Kilovoltage-Switching Dual-Energy CT in Cystic and Solid Renal Masses.
    Krishna S; Sadoughi N; McInnes MDF; Chatelain R; MacDonald DB; Schieda N
    AJR Am J Roentgenol; 2018 Oct; 211(4):789-796. PubMed ID: 30106611
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Utility of virtual unenhanced images and split-bolus injection using spectral multidetector CT for the assessment of renal cell carcinoma conspicuity and radiation dose.
    Wang W; Liu L; Zeng H; Sun C; Huang N; Zhang M
    Int J Clin Pract; 2016 Sep; 70 Suppl 9B():B56-63. PubMed ID: 27577516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is biochemical screening for pheochromocytoma in adrenal incidentalomas expressing low unenhanced attenuation on computed tomography necessary?
    Sane T; Schalin-Jäntti C; Raade M
    J Clin Endocrinol Metab; 2012 Jun; 97(6):2077-83. PubMed ID: 22492870
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic Accuracy of Attenuation Difference and Iodine Concentration Thresholds at Rapid-Kilovoltage-Switching Dual-Energy CT for Detection of Enhancement in Renal Masses.
    Sadoughi N; Krishna S; Macdonald DB; Chatelain R; Flood TA; McInnes MDF; Schieda N
    AJR Am J Roentgenol; 2019 Sep; 213(3):619-625. PubMed ID: 31120787
    [No Abstract]   [Full Text] [Related]  

  • 52. Adrenal masses: characterization with delayed contrast-enhanced CT.
    Boland GW; Hahn PF; Peña C; Mueller PR
    Radiology; 1997 Mar; 202(3):693-6. PubMed ID: 9051018
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of CT findings in symptomatic and incidentally discovered pheochromocytomas.
    Motta-Ramirez GA; Remer EM; Herts BR; Gill IS; Hamrahian AH
    AJR Am J Roentgenol; 2005 Sep; 185(3):684-8. PubMed ID: 16120918
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
    Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
    Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Homogeneous high attenuation renal cysts and solid masses--differentiation with single phase dual energy computed tomography.
    Liu Xl; Zhou Jj; Zeng MS; Ma Zp; Ding Yq
    Clin Radiol; 2013 Apr; 68(4):e198-205. PubMed ID: 23352763
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lipid-poor adenomas on unenhanced CT: does histogram analysis increase sensitivity compared with a mean attenuation threshold?
    Ho LM; Paulson EK; Brady MJ; Wong TZ; Schindera ST
    AJR Am J Roentgenol; 2008 Jul; 191(1):234-8. PubMed ID: 18562751
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis.
    Lee MJ; Hahn PF; Papanicolaou N; Egglin TK; Saini S; Mueller PR; Simeone JF
    Radiology; 1991 May; 179(2):415-8. PubMed ID: 2014283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 18F-FDG PET/CT in the evaluation of adrenal masses.
    Metser U; Miller E; Lerman H; Lievshitz G; Avital S; Even-Sapir E
    J Nucl Med; 2006 Jan; 47(1):32-7. PubMed ID: 16391184
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relative Enhancement Ratio of Portal Venous Phase to Unenhanced CT in the Diagnosis of Lipid-poor Adrenal Adenomas.
    Nagayama Y; Inoue T; Kato Y; Tanoue S; Kidoh M; Oda S; Nakaura T; Hirai T
    Radiology; 2021 Nov; 301(2):360-368. PubMed ID: 34463552
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Split-Bolus Portal Venous Phase Dual-Energy CT Urography: Protocol Design, Image Quality, and Dose Reduction.
    Chen CY; Hsu JS; Jaw TS; Shih MC; Lee LJ; Tsai TH; Liu GC
    AJR Am J Roentgenol; 2015 Nov; 205(5):W492-501. PubMed ID: 26496571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.